<?xml version="1.0" encoding="UTF-8"?>
<ref id="C177">
 <label>177</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Toniati</surname>
    <given-names>P</given-names>
   </name>, 
   <name name-style="western">
    <surname>Piva</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Cattalini</surname>
    <given-names>M</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy</article-title>. 
  <source>Autoimmun Rev</source>
  <year>2020</year>; 
  <volume>19</volume>: 
  <fpage>102568</fpage>. doi:
  <pub-id pub-id-type="doi">10.1016/j.autrev.2020.102568</pub-id>
  <pub-id pub-id-type="pmid">32376398</pub-id>
 </mixed-citation>
</ref>
